Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients

Damkier Per

首页> 外文期刊>Journal of Turbulence >Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients

【24h】

Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients

机译：不要以为两点是正确的：Tamoxifen和Cyp2D6基因分型治疗乳腺癌患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of Turbulence》 |2017年第8期|共2页
作者
Damkier Per;
展开▼
作者单位

Odense Univ Hosp Dept Clin Biochem &

Pharmacol Odense Denmark;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类流体力学;
关键词

相似文献

外文文献
中文文献
专利

1. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [J] . Paul D. P. Pharoah Jean Abraham and Carlos Caldas Journal of the National Cancer Institute . 2012,第16期

机译：Re：CYP2D6基因型和他莫昔芬对内分泌反应性乳腺癌的绝经后妇女的反应：国际乳腺癌组织1-98试验和Re：CYP2D6和UGT2B7基因型与他莫昔芬治疗的乳腺癌患者的复发风险
2. Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients [J] . Damkier Per Pharmacogenomics . 2017,第8期

机译：不要以为两点是正确的：Tamoxifen和Cyp2D6基因分型治疗乳腺癌患者
3. Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients [J] . Damkier Per Journal of Turbulence . 2017,第8期

机译：不要以为两点是正确的：Tamoxifen和Cyp2D6基因分型治疗乳腺癌患者
4. Candidate biomarkers for response to tamoxifen in breast cancer metastatic patients [C] . Cava Claudia, Bertoli Gloria, Zoppis Italo, IEEE International Conference on Bioinformatics and Bioengineering . 2013

机译：乳腺癌转移患者对他莫昔芬反应的候选生物标志物
5. Tamoxifen use, adherence to therapy, and quality of life in older breast cancer patients. [D] . Newell, Debra Ann. 2003

机译：他莫昔芬的使用，对治疗的依从性以及老年乳腺癌患者的生活质量。
6. Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes [O] . Philipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, 2014

机译：他莫昔芬治疗不同CYP2D6基因型绝经前乳腺癌患者的体外细胞模拟
7. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients [O] . P. D. P. Pharoah, J. Abraham, C. Caldas 2012

机译：Re：Cyp2D6基因型和三种毒素反应患有内分泌响应乳腺癌的绝经后妇女：乳房国际组1-98试验和RE：CYP2D6和UGT2B7基因型和制革治疗乳腺癌患者的复发风险
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients

著录项

引文网络

相似文献

相关主题

期刊订阅